Ubiquitin-specific protease 22-induced autophagy is correlated with poor prognosis of pancreatic cancer

Oncology Reports

Volumn 32, Issue 6, 2014, Pages 2726-2734

  Liang, Jin Xiao ^a   Ning, Zhen ^b   Gao, Wei ^b   Ling, Jun ^c   Wang, A Man ^b   Luo, Hai Feng ^b   Liang, Yong ^d   Yan, Qiu ^b   Wang, Zhong Yu ^b  

^a ZHEJIANG CANCER HOSPITAL   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c Geisinger Health Geisinger Commonwealth School of Medicine   (United States)

^d TAIZHOU UNIVERSITY   (China)

Author keywords

Autophagy; LC3; Pancreatic cancer; Prognosis; Ubiquitin specific protease 22

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 3 METHYLADENINE; DEUBIQUITINASE; GEMCITABINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; PROTEIN LC3; REGULATOR PROTEIN; SHORT HAIRPIN RNA; UBIQUITIN SPECIFIC PROTEASE 22; UNCLASSIFIED DRUG; REACTIVE OXYGEN METABOLITE; THIOL ESTER HYDROLASE; USP22 PROTEIN, HUMAN;

ADULT; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CANCER INHIBITION; CANCER PROGNOSIS; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG POTENTIATION; DRUG RESISTANCE; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREATIC CANCER CELL LINE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; TUMOR INVASION; AGED; APOPTOSIS; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE;

AGED; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; REACTIVE OXYGEN SPECIES; THIOLESTER HYDROLASES;

EID: 84914706966     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3508     Document Type: Article

References (38)

1. Gukovskaya AS and Pandol SJ: Cell death pathways in pancreatitis and pancreatic cancer. Pancreatology 4: 567-586, 2004.
2. Glinsky GV, Berezovska O and Glinskii AB: Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 115: 1503-1521, 2005.
3. Glinsky GV: 'Stemness' genomics law governs clinical behavior of human cancer: implications for decision making in disease management. J Clin Oncol 26: 2846-2853, 2008.
4. Atanassov BS, Evrard YA, Multani AS, et al: Gcn5 and SAGA regulate shelterin protein turnover and telomere maintenance. Mol Cell 35: 352-364, 2009.
5. Zhang XY, Varthi M, Sykes SM, et al: The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression. Mol Cell 29: 102-111, 2008.
6. Zhao Y, Lang G and Ito S, et al: A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing. Mol Cell 29: 92-101, 2008.
7. Lee HJ, Kim MS, Shin JM, Park TJ, Chung HM and Baek KH: The expression patterns of deubiquitinating enzymes, USP22 and Usp22. Gene Expr Patterns 6: 277-284, 2006.
8. Liu YL, Yang YM, Xu H and Dong XS: Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer. J Gastroenterol Hepatol 25: 1800-1805, 2010.
9. Liu YL, Yang YM, Xu H and Dong XS: Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer. J Surg Oncol 103: 283-289, 2011.
10. Yang DD, Cui BB, Sun LY, et al: The co-expression of USP22 and BMI-1 may promote cancer progression and predict therapy failure in gastric carcinoma. Cell Biochem Biophys 61: 703-710, 2011.
11. Zhang Y, Yao L and Zhang X, et al: Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer. J Cancer Res Clin Oncol 137: 1245-1253, 2011.
12. Lv L, Xiao XY, Gu ZH, Zeng FQ, Huang LQ and Jiang GS: Silencing USP22 by asymmetric structure of interfering RNA inhibits proliferation and induces cell cycle arrest in bladder cancer cells. Mol Cell Biochem 346: 11-21, 2011.
13. Ning J, Zhang J, Liu W, Lang Y, Xue Y and Xu S: Overexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer. Eur J Histochem 56: e46, 2012.
14. Ling SB, Sun DG and Tang B, et al: Knock-down of USP22 by small interfering RNA interference inhibits HepG2 cell proliferation and induces cell cycle arrest. Cell Mol Biol 58 (Suppl): OL1803-OL1808, 2012.
15. Vivanco I and Sawyers CL: The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501, 2002.
16. Ogier-Denis E and Codogno P: Autophagy: a barrier or an adaptive response to cancer. Biochim Biophys Acta 1603: 113-128, 2003.
17. Pattingre S, Bauvy C and Codogno P: Amino acids interfere with the ERK1/2-dependent control of macroautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells. J Biol Chem 278: 16667-16674, 2003.
18. Pardo R, Lo Ré A, Archange C, et al: Gemcitabine induces the VMP1-mediated autophagy pathway to promote apoptotic death in human pancreatic cancer cells. Pancreatology 10: 19-26, 2010.
19. Tung WL, Wang Y, Gout PW, Liu DM, Gleave M and Wang Y: Use of irinotecan for treatment of small cell carcinoma of the prostate. Prostate 71: 675-681, 2011.
20. Mathew R, Karantza-Wadsworth V and White E: Role of autophagy in cancer. Nat Rev Cancer 7: 961-967, 2007.
21. Debnath J, Baehrecke EH and Kroemer G: Does autophagy contribute to cell death? Autophagy 1: 66-74, 2005.
22. Li J, Hou N, Faried A, Tsutsumi S and Kuwano H: Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model. Eur J Cancer 46: 1900-1909, 2010.
23. Liu F, Liu D, Yang Y and Zhao S: Effect of autophagy inhibition on chemotherapy-induced apoptosis in A549 lung cancer cells. Oncol Lett 5: 1261-1265, 2013.
24. Shingu T, Fujiwara K, Bögler O, et al: Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells. Int J Cancer 124: 1060-1071, 2009.
25. Fujii S, Mitsunaga S, Yamazaki M, et al: Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. Cancer Sci 99: 1813-1819, 2008.
26. Yang S and Kimmelman AC: A critical role for autophagy in pancreatic cancer. Autophagy 7: 912-913, 2011.
27. Yang S, Wang X, Contino G, et al: Pancreatic cancers require autophagy for tumor growth. Genes Dev 25: 717-729, 2011.
28. Rausch V, Liu L, Apel A, et al: Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment. J Pathol 227: 325-335, 2012.
29. Egner JR: AJCC cancer staging manual. JAMA 304: 1726-1727, 2010.
30. Gillett CE: Immunohistochemistry. Methods Mol Med 120: 191-200, 2006.
31. Cherra SR III, Kulich SM, Uechi G, et al: Regulation of the autophagy protein LC3 by phosphorylation. J Cell Biol 190: 533-539, 2010.
32. Jiang H, Cheng D, Liu W, Peng J and Feng J: Protein kinase C inhibits autophagy and phosphorylates LC3. Biochem Biophys Res Commun 395: 471-476, 2010.
33. Levine B and Klionsky DJ: Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6: 463-477, 2004.
34. Guerra C, Collado M, Navas C, et al: Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 19: 728-739, 2011.
35. Neesse A, Michl P, Frese KK, et al: Stromal biology and therapy in pancreatic cancer. Gut 60: 861-868, 2011.
36. Burris HR, Moore MJ, Andersen J, et al: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15: 2403-2413, 1997.
37. Donadelli M, Dando I, Zaniboni T, et al: Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. Cell Death Dis 2: e152, 2011.
38. DeNicola GM, Karreth FA, Humpton TJ, et al: Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475: 106-109, 2011.